Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP TMS SA : EDAP TMS SA to Announce Second Quarter 2018 Financial Results on Thursday, August 30
LYON, France , July 24, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the second quarter and six months ended June 30, 2018 , before the open of the financial markets on Thursday, August 30, 2018 .
View HTML
Toggle Summary EDAP TMS SA : EDAP Announces FDA Clearance for Focal One®
AUSTIN, TX , LYON, FRANCE -- JUNE 7, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced that it has received 510(k) clearance from the US Food and Drug Administration ( FDA ) for its Focal One device for the ablation of prostate tissue. 
View HTML
Toggle Summary EDAP TMS SA : EDAP Reports 2018 First Quarter Results
2018 Q1 total revenue records a 6% increase year-over-year Focal One Final Additional Information submitted to FDA early May EDAP to attend American Urological Association congress in San Francisco , May 18-21, 2018 LYON, France , May 14, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the
View HTML
Toggle Summary EDAP TMS SA : EDAP TMS SA to Announce First Quarter 2018 Financial Results on Monday, May 14
LYON, France , May 2, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2018 , after the close of the financial markets on Monday, May 14, 2018 .
View HTML
Toggle Summary EDAP TMS SA : EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes
Clinical Results Presented at the Southeastern Section of the American Urological Association Confirms HIFU's Safety, Efficacy and Benefits for Patients' Quality Of Life LYON, FRANCE , AUSTIN, TX -- APRIL 3, 2018 - EDAP TMS (Nasdaq: EDAP) today announced that preliminary results of the first U.S.
View HTML
Toggle Summary EDAP TMS SA : EDAP Reports 2017 Annual Results
2017 Highlights 2017 revenue on par with 2016; lower HIFU capital equipment sales offset by double-digit HIFU treatment revenue growth   CMS issued C-Code allocation for reimbursement of HIFU for prostate tissue ablation in July CIGNA to reimburse HIFU as salvage therapy for prostate cancer
View HTML
Toggle Summary EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure
Insurer Takes its Cue from Updated NCCN Guidelines, Which Recognizes HIFU as Salvage Treatment for Prostate Cancer Lyon, France , Austin, TX -- March 21, 2018 - EDAP TMS SA (Nasdaq: EDAP) today announced that CIGNA became the first major U.S. private health insurance company to reimburse prostate
View HTML
Toggle Summary EDAP TMS SA : EDAP TMS to Announce Year End 2017 Financial Results on Tuesday, March 27, 2018
LYON, France , March 14, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the year ended December 31, 2017 , after the close of the financial markets on Tuesday, March 27, 2018 .
View HTML
Toggle Summary EDAP's Focal One® Robotic HIFU Treatments Performed at Acibadem Hospital, Istanbul, Turkey
  LYON, France , December 18, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first HIFU treatments performed at Acibadem Hospital , Istanbul, Turkey , using the Company's Focal One Robotic HIFU device.   Prof.
View HTML
Toggle Summary EDAP TMS Reports Third Quarter 2017 Results
EDAP TMS Reports Third Quarter 2017 Results  EDAP's HIFU patient treatment revenues grew 29% compared to third quarter 2016. EDAP received FDA clearance for its Ablatherm Fusion ®  late in the quarter. EDAP's cash position remains strong at US $21.3 million on September 30, 2017 LYON, France ,
View HTML